Home » Topics » Science, BioWorld MedTech

Science, BioWorld MedTech
RSS

Bioworld MedTech’s Cardiology Extra for Dec. 9, 2019

December 9, 2019

Keeping you up to date on recent developments in cardiology.

Bioworld MedTech’s Neurology Extra for Dec. 6, 2019

December 6, 2019

By Andrea Applegate

Keeping you up to date on recent developments in neurology.

Bioworld MedTech’s Diagnostics Extra for Dec. 5, 2019

December 5, 2019

By Meg Bryant and Anette Breindl

Keeping you up to date on recent developments in diagnostics.

Bioworld MedTech’s Orthopedics Extra for Dec. 4, 2019

December 4, 2019

By Holland Johnson

Keeping you up to date on recent developments in orthopedics.

Bioworld MedTech’s Oncology Extra for Dec. 3, 2019

December 3, 2019

By Mark McCarty

Keeping you up to date on recent developments in oncology.

‘Absolutely fascinating’

Stem cells, dead cells work equally well for heart repair

December 2, 2019

By Anette Breindl

A study published in the Nov. 27, 2019, advance online issue of Nature manages a rare feat. It is both a vindication of and egg in the face for cardiac stem cell research.

Bioworld MedTech’s Cardiology Extra

December 2, 2019

By Liz Hollis and Anette Breindl

Keeping you up to date on recent developments in cardiology.

There’s an app for THAT?!

Web-based tool facilitates new antibiotic development

November 27, 2019

A new web-based tool allowing rapid in silico prediction of the ability of candidate antibiotics to accumulate in Gram-negative bacteria should enable subsequent prioritization of new compounds for synthesis and further evaluation, U.S. researchers reported Nov. 18, 2019, in Nature Microbiology.

Bioworld MedTech’s Orthopedics Extra

November 27, 2019

By Holland Johnson

Keeping you up to date on recent developments in orthopedics.

stem-cells

Australian researchers create kidney tissue from iPS cells

November 26, 2019

MELBOURNE, Australia – Researchers at the Murdoch Children’s Research Institute in Melbourne are pushing the boundaries on creating kidney tissue from stem cells. For more than two decades, Melissa Little and her team at Murdoch have investigated the molecular and cell development basis of kidney disease and the potential for regeneration. The team has developed approaches for directing the differentiation of human pluripotent stem cells to human kidney organoids and is applying that knowledge to disease modeling, drug screening, cell therapy and tissue engineering.

Popular Stories

Insulet to launch wearable insulin pump this year, works with Dexcom iCGM for closed loop
BioWorld MedTech
SAN FRANCISCO – Insulet Corp. aims to get an FDA approval this year and launch its first interoperable device, the cord-free, wearable insulin device Omnipod...
China launches price war to reshuffle pharma industry; Bayer cuts prices by 90% to secure market
BioWorld
China announced Jan. 17 which further pharmaceutical companies it will buy from under its centralized procurement program that seeks the lowest prices. The price...
Thiel calls for improving research grant, regulatory processes to enhance scientific innovation
BioWorld
SANTA CLARA, Calif. – Peter Thiel is not a fan of incremental science. The high-profile venture capital investor, who invests across technology and the life...
Year in Review: From capital markets to CRISPR, 2019 a pretty good year for biopharma
BioWorld
For biopharma, 2019 can be described as a terrific year – with a few asterisks. The financial markets were flourishing, with venture capital dollars, in...
Novavax developing nanoparticle vaccine for Wuhan coronavirus
BioWorld
In response to the emergence of a new coronavirus seen recently in China, and now America, Novavax Inc. has initiated development of a vaccine candidate, the...

cortellis ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.